Trial Profile
25-Gauge Vitrectomy Combine With Ranibizumab or Triamcinolone Acetonide on Proliferative Diabetic Retinopathy in Chinese Patients
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary) ; Triamcinolone (Primary)
- Indications Diabetic retinopathy
- Focus Therapeutic Use
- Acronyms RaTAPDR
- 23 Aug 2016 Planned End Date changed from 1 Mar 2016 to 1 May 2017.
- 23 Aug 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Mar 2017.
- 30 Mar 2015 Status changed from not yet recruiting to recruiting, according to to ClinicalTrials.gov record.